Array Technologies (ARRY)
(Real Time Quote from BATS)
$10.73 USD
-0.01 (-0.09%)
Updated May 21, 2024 11:33 AM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Brokerage Reports
Array Technologies, Inc. [ARRY]
Reports for Purchase
Showing records 501 - 520 ( 530 total )
Company: Array Technologies, Inc.
Industry: Solar
Company: Array Technologies, Inc.
Industry: Solar
Initiating at Buy on Strong Growth and Industry Position
Provider: Roth Capital Partners, Inc.
Analyst: SHEN P
Company: Array Technologies, Inc.
Industry: Solar
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Array BioPharma Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Array BioPharma Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2Q11 numbers; waiting for selumetinib (MEK inhibitor) data this year
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2Q11 numbers; waiting for selumetinib (MEK inhibitor) data this year
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
KSP inhibitor looks good in heavily pretreated Multiple Myeloma patients
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S